The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 156 participants.

Also called NCT02870764

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 156 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02870764
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02870764. Randomized; triple masking; primary purpose treatment. Start 2016-09 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris
Acronym
DOLPHIN
Condition
Angina, Stable
Condition
Inflammation
Intervention (Drug)
Dan-shen extract
Intervention (Drug)
Placebo
Intervention (Other)
Standard medical care
Lead sponsor
Taizhou Fourth People's Hospital (class: other)
Collaborator
Shanghai 10th People's Hospital (class: other)

Record details

Record id
cardio:ct-nct02870764
Content hash
ff796f479e8719e42ae8f42ac9a2a86d531f31d13f90a06d459546067eaf5e05